|
| 36720762 | How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study. | | 2023 |
| 35699504 | Pediatric oncologists' perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey-based cross-sectional study. | Cancer Reports | 2023 |
| 38047716 | Post-traumatic growth in parents of long-term childhood cancer survivors compared to the general population: AÂ report from the Swiss childhood cancer survivor study-Parents. | | 2023 |
| 36715306 | Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups. | Neuro Oncol | 2023 |
| 36772880 | Worries and anxiety in parents of adult survivors of childhood cancer: A report from the Swiss Childhood Cancer Survivor Study-Parents. | | 2023 |
| 37201023 | Case report: Hepatotoxicity and nephrotoxicity induced by methotrexate in a paediatric patient, what is the role of precision medicine in 2023? | | 2023 |
| 36815329 | [Precision medicine in the treatment of pediatric cancers]. | | 2023 |
| 37239184 | Pediatric Posterior Fossa ATRT: A Case Report, New Treatment Strategies and Perspectives. | | 2023 |
| 35327783 | Educational Attainment and Employment Outcome of Survivors of Pediatric CNS Tumors in Switzerland-A Report from the Swiss Childhood Cancer Survivor Study. | Children | 2022 |
| 35814457 | Neurological Symptom Improvement After Re-Irradiation in Patients With Diffuse Intrinsic Pontine Glioma: A Retrospective Analysis of the SIOP-E-HGG/DIPG Project. | Front Oncol | 2022 |
| 35733513 | Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates. | Neurooncol Adv | 2022 |
| 33908610 | Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. | Neuro Oncol | 2022 |
| 35190934 | Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies. | J Neurooncol | 2022 |
| 35151105 | Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial. | Eur J Cancer | 2022 |
| 35074812 | Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol. | BMJ Open | 2022 |
| 34595479 | Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors. | Neurooncol Adv | 2021 |
| 33479826 | Trigeminal nerve chronic motor denervation caused by cerebellar peduncle pilocytic astrocytoma. | Child's Nervous System | 2021 |
| 33939330 | Ketogenic diet treatment in diffuse intrinsic pontine glioma in children: Retrospective analysis of feasibility, safety, and survival data. | Cancer Reports | 2021 |
| 34373263 | The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets. | Cancer Discov | 2021 |
| 32514758 | CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort. | Acta Neuropathol | 2020 |
| 31971950 | Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment. | PLoS One | 2020 |
| 32135104 | Cerebrospinal fluid evaluation in adult patients with medulloblastoma. | Lancet Oncol | 2020 |
| 32474813 | Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome. | Childs Nerv Syst | 2020 |
| 32330099 | Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort. | J Clin Oncol | 2020 |
| 33305077 | Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial. | Adv Radiat Oncol | 2020 |
| 31022591 | Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience. | Eur J Cancer | 2019 |
| 31727173 | Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort. | Acta Neuropathol Commun | 2019 |
| 30767367 | Comment on: Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: A safety and feasibility study. | Pediatric Blood and Cancer | 2019 |
| 31522324 | Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand? | J Neurooncol | 2019 |
| 30693642 | Occurrence of high-grade glioma in Noonan syndrome: Report of two cases. | Pediatr Blood Cancer | 2019 |
| 29785560 | A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)". | Acta Neuropathologica | 2018 |
| 29016894 | Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. | Neuro Oncol | 2018 |
| 29022050 | Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients. | Strahlentherapie und Onkologie | 2018 |
| 30159736 | Correction to: A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)". | Acta Neuropathologica | 2018 |
| 29971034 | Concurrent <i>IDH1</i> and <i>SMARCB1</i> Mutations in Pediatric Medulloblastoma: A Case Report. | Front Neurol | 2018 |
| 29667083 | Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients? | Journal of Neuro-Oncology | 2018 |
| 29746225 | Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. | J Clin Oncol | 2018 |
| 28161497 | Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. | Eur J Cancer | 2017 |
| 28695340 | Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response. | Childs Nerv Syst | 2017 |
| 28586748 | Haematological malignancies following temozolomide treatment for paediatric high-grade glioma. | European Journal of Cancer | 2017 |
| 28617804 | Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification. | PLoS One | 2017 |
| 28969094 | High-grade glioma in very young children: a rare and particular patient population. | Oncotarget | 2017 |
| 28966033 | Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. | Cancer Cell | 2017 |
| 27858266 | Reverse phase protein arrays enable glioblastoma molecular subtyping. | J Neurooncol | 2017 |
| 28168833 | Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. | Am J Med Genet A | 2017 |
| 28110411 | Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease. | J Neurooncol | 2017 |
| 27863192 | Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters. | J Clin Oncol | 2016 |
| 26883117 | MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties. | BMC Cancer | 2016 |
| 27099149 | Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome. | Blood | 2016 |
| 26919435 | New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. | Cell | 2016 |